Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GPI Nil Holdings is a holding company primarily associated with the healthcare and pharmaceutical sectors, specifically acting as an investment vehicle for the GPI Group (Global Pharma Innovators). The company is involved in the strategic management and financing of healthcare-related entities, including those focused on pharmaceutical distribution, retail pharmacy chains, and medical services. It plays a key role in the corporate structure of healthcare providers in emerging markets, particularly in the Middle East and North Africa (MENA) region. The entity serves as a parent or major shareholder for various operating subsidiaries that provide essential medical products and services to the public.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GPI Nil Holdings.